164 related articles for article (PubMed ID: 32134755)
21. Numerical chromosomal abnormality in gastric MALT lymphoma and diffuse large B-cell lymphoma.
Watanobe I; Takamori S; Kojima K; Fukasawa M; Beppu T; Futagawa S; Hirai S
J Gastroenterol; 2002; 37(9):691-6. PubMed ID: 12375141
[TBL] [Abstract][Full Text] [Related]
22. Helicobacter pylori cagA status and gastric mucosa-associated lymphoid tissue lymphoma: a systematic review and meta-analysis.
Keikha M; Sahebkar A; Yamaoka Y; Karbalaei M
J Health Popul Nutr; 2022 Jan; 41(1):2. PubMed ID: 34980267
[TBL] [Abstract][Full Text] [Related]
23. The role of Helicobacter pylori eradication in the treatment of diffuse large B-cell and marginal zone lymphomas of the stomach.
Ferreri AJ; Govi S; Ponzoni M
Curr Opin Oncol; 2013 Sep; 25(5):470-9. PubMed ID: 23942292
[TBL] [Abstract][Full Text] [Related]
24. Expressions of the CagA protein and CagA-signaling molecules predict Helicobacter pylori dependence of early-stage gastric DLBCL.
Kuo SH; Chen LT; Lin CW; Yeh KH; Shun CT; Tzeng YS; Liou JM; Wu MS; Hsu PN; Cheng AL
Blood; 2017 Jan; 129(2):188-198. PubMed ID: 27864293
[TBL] [Abstract][Full Text] [Related]
25. Accumulation of aberrant CpG hypermethylation by Helicobacter pylori infection promotes development and progression of gastric MALT lymphoma.
Kondo T; Oka T; Sato H; Shinnou Y; Washio K; Takano M; Morito T; Takata K; Ohara N; Ouchida M; Shimizu K; Yoshino T
Int J Oncol; 2009 Sep; 35(3):547-57. PubMed ID: 19639175
[TBL] [Abstract][Full Text] [Related]
26. Gastric mucosa-associated lymphoid tissue lymphomas and Helicobacter pylori infection: a Colombian perspective.
Yepes S; Torres MM; Saavedra C; Andrade R
World J Gastroenterol; 2012 Feb; 18(7):685-91. PubMed ID: 22363141
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K/AKT pathway in diffuse large B-cell lymphoma.
Go H; Jang JY; Kim PJ; Kim YG; Nam SJ; Paik JH; Kim TM; Heo DS; Kim CW; Jeon YK
Oncotarget; 2015 Jun; 6(17):15035-49. PubMed ID: 25909227
[TBL] [Abstract][Full Text] [Related]
28. Expression of cdc2 and cyclin B1 in Helicobacter pylori-associated gastric MALT and MALT lymphoma : relationship to cell death, proliferation, and transformation.
Banerjee SK; Weston AP; Zoubine MN; Campbell DR; Cherian R
Am J Pathol; 2000 Jan; 156(1):217-25. PubMed ID: 10623670
[TBL] [Abstract][Full Text] [Related]
29. Etiology and therapy of Helicobacter pylori-associated gastric lymphomas.
Wündisch T; Kim TD; Thiede C; Morgner A; Alpen B; Stolte M; Neubauer A
Ann Hematol; 2003 Sep; 82(9):535-45. PubMed ID: 12845479
[TBL] [Abstract][Full Text] [Related]
30. CagA Phosphorylation in Helicobacter pylori-Infected B Cells Is Mediated by the Nonreceptor Tyrosine Kinases of the Src and Abl Families.
Krisch LM; Posselt G; Hammerl P; Wessler S
Infect Immun; 2016 Sep; 84(9):2671-80. PubMed ID: 27382024
[TBL] [Abstract][Full Text] [Related]
31. Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status.
Nakamura T; Seto M; Tajika M; Kawai H; Yokoi T; Yatabe Y; Nakamura S
Am J Gastroenterol; 2008 Jan; 103(1):62-70. PubMed ID: 17894851
[TBL] [Abstract][Full Text] [Related]
32. The
Della Bella C; Soluri MF; Puccio S; Benagiano M; Grassi A; Bitetti J; Cianchi F; Sblattero D; Peano C; D'Elios MM
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502367
[TBL] [Abstract][Full Text] [Related]
33. A case of
Fujita A; Tajika M; Tanaka T; Ishihara M; Hirayama Y; Mizuno N; Hara K; Hijioka S; Imaoka H; Yoshida T; Okuno N; Hieda N; Hirayama T; Shibuya H; Kondo H; Suzuki H; Toriyama K; Yatabe Y; Yamao K; Niwa Y
Nagoya J Med Sci; 2017 Feb; 79(2):251-257. PubMed ID: 28626260
[No Abstract] [Full Text] [Related]
34. Significance of CXCR3 expression in gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type for predicting responsiveness to Helicobacter pylori eradication.
Yamamoto H; Nakamura T; Matsuo K; Tajika M; Kawai H; Ohmiya N; Niwa Y; Goto H; Nakamura S
Cancer Sci; 2008 Sep; 99(9):1769-73. PubMed ID: 18616679
[TBL] [Abstract][Full Text] [Related]
35. Helicobacter pylori-gastrin link in MALT lymphoma.
Konturek PC; Konturek SJ; Starzyska T; Marlicz K; Bielanski W; Pierzchalski P; Karczewska E; Hartwich A; Rembiasz K; Lawniczak M; Ziemniak W; Hahn EC
Aliment Pharmacol Ther; 2000 Oct; 14(10):1311-8. PubMed ID: 11012476
[TBL] [Abstract][Full Text] [Related]
36. Histopathologic features and expression of Bcl-2 and p53 proteins in primary gastric lymphomas.
Dogusoy G; Karayel FA; Göcener S; Göksel S
Pathol Oncol Res; 1999; 5(1):36-40. PubMed ID: 10079376
[TBL] [Abstract][Full Text] [Related]
37. Helicobacter pylori virulence factor CagA promotes tumorigenesis of gastric cancer via multiple signaling pathways.
Yong X; Tang B; Li BS; Xie R; Hu CJ; Luo G; Qin Y; Dong H; Yang SM
Cell Commun Signal; 2015 Jul; 13():30. PubMed ID: 26160167
[TBL] [Abstract][Full Text] [Related]
38. Helicobacter pylori CagA protein induces gastric cancer stem cell-like properties through the Akt/FOXO3a axis.
Chen ZW; Dong ZB; Xiang HT; Chen SS; Yu WM; Liang C
J Cell Biochem; 2024 Mar; 125(3):e30527. PubMed ID: 38332574
[TBL] [Abstract][Full Text] [Related]
39. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma.
Chen LT; Lin JT; Tai JJ; Chen GH; Yeh HZ; Yang SS; Wang HP; Kuo SH; Sheu BS; Jan CM; Wang WM; Wang TE; Wu CW; Chen CL; Su IJ; Whang-Peng J; Cheng AL
J Natl Cancer Inst; 2005 Sep; 97(18):1345-53. PubMed ID: 16174856
[TBL] [Abstract][Full Text] [Related]
40. Helicobacter pylori eradication therapy is effective in the treatment of early-stage H pylori-positive gastric diffuse large B-cell lymphomas.
Kuo SH; Yeh KH; Wu MS; Lin CW; Hsu PN; Wang HP; Chen LT; Cheng AL
Blood; 2012 May; 119(21):4838-44; quiz 5057. PubMed ID: 22403257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
